Brought to you by 
Neurology-focused nVNS device company electroCore nets $83.4mm in IPO
06 Jul 2018
Executive Summary
Noninvasive vagus nerve stimulation (nVNS) device company electroCore Inc. (focused on neurology and rheumatology) netted $83.4mm in its initial public offering of 5.98mm shares (including the overallotment) at $15, the midpoint of its proposed range. The company originally planned to sell 4.33mm shares.
Deal Industry
- Medical Devices
-
Medical Devices
- Rehabilitation Equipment and Devices
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Neurology-focused nVNS device company electroCore nets $83.4mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice